Korea Lowers Medical Cost For Rare Disease Patients, Eases Off-Label Use Rules
Executive Summary
In an ongoing effort to improve access to drugs and provide more treatment options for rare disease patients, South Korea unveils new steps to lower their treatment costs and expand the scope of what are considered rare diseases.